GlassScriptPhysician profile
Ryan G Aleong
NPI 1174589113
$33,049.80
in general payments reported to CMS, 2019-2025
20 companies · $2,798 in 2025
The $2,798 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,986 · 2020: $3,535 · 2021: $1,020 · 2022: $5,341 · 2023: $13K · 2024: $4,209 · 2025: $2,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,471 · Food and Beverage: $6,712 · Grant: $4,185 · Consulting Fee: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,470.90 |
| Food and Beverage | $6,712.39 |
| Grant | $4,184.65 |
| Consulting Fee | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $10,332.98 | 2019-2025 | Plexa Promri, Acticor 7 Vr-T Dx, Biomonitor |
| Medtronic, INC. | $9,637.89 | 2021-2025 | Micra, Attain Command + Surevalve, Sensia |
| Medical Device Business Services, INC. | $5,400.00 | 2021-2023 | Carto 3 |
| Boston Scientific Corporation | $4,164.14 | 2022-2025 | Farapulse, Watchman, Watchman Access System |
| Abbott Laboratories | $1,861.99 | 2019-2025 | Tacticath Ablation Catheter, Sensor Enabled, Ensite, Ensite Precision |
| Biosense Webster, INC. | $683.62 | 2022-2025 | Carto 3, Qdot Micro Catheter |
| Atricure, INC. | $179.10 | 2023 | |
| Medtronic Vascular, INC. | $140.46 | 2019 | |
| W. L. Gore & Associates, INC. | $127.04 | 2025 | Gore Cardioform Septal Occluder |
| Heartflow, INC. | $108.56 | 2019-2025 | |
| Angiodynamics, INC. | $107.83 | 2022 | |
| Cardiofocus, INC. | $68.69 | 2019 | |
| Scpharmaceuticals INC. | $46.88 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $45.43 | 2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $34.18 | 2025 | Evkeeza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $30.03 | 2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $24.98 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.73 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.13 | 2025 | Lifevest |
| Philips North America LLC | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Aleong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.